Compare TELA & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TELA | COHN |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5M | 37.3M |
| IPO Year | 2019 | 2003 |
| Metric | TELA | COHN |
|---|---|---|
| Price | $0.57 | $15.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 152.0K | 18.6K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 37.59 | ★ 5537.50 |
| EPS | N/A | ★ 4.35 |
| Revenue | $80,275,000.00 | ★ $275,564,000.00 |
| Revenue This Year | $17.75 | N/A |
| Revenue Next Year | $16.45 | N/A |
| P/E Ratio | ★ N/A | $3.82 |
| Revenue Growth | 15.84 | ★ 246.19 |
| 52 Week Low | $0.50 | $6.10 |
| 52 Week High | $2.19 | $32.60 |
| Indicator | TELA | COHN |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 52.43 |
| Support Level | N/A | $14.78 |
| Resistance Level | $1.24 | $20.19 |
| Average True Range (ATR) | 0.12 | 1.13 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 24.18 | 62.40 |
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.